Related Experiment Video
Updated: Mar 28, 2026

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
Published on: June 11, 2014
Novel Morphologic and Genetic Analysis of Cancer Cells in a 3D Microenvironment Identifies STAT3 as a Regulator of
Min Chul Park1, Hyobin Jeong2, Sung Hwa Son3
1Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. Advanced Institutes of Convergence Technology, Seoul National University, Suwon, Korea.
Abstract:
Tumor permeability is a critical determinant of drug delivery and sensitivity, but systematic methods to identify factors that perform permeability barrier functions in the tumor microenvironment are not yet available. Multicellular tumor spheroids have become tractable in vitro models to study the impact of a three-dimensional (3D) environment on cellular behavior. In this study, we characterized the spheroid-forming potential of cancer cells and correlated the resulting spheroid morphologies with genetic information to identify conserved cellular processes associated with spheroid structure. Spheroids generated from 100 different cancer cell lines were classified into four distinct groups based on morphology. In particular, round and compact spheroids exhibited highly hypoxic inner cores and permeability barriers against anticancer drugs. Through systematic and correlative analysis, we reveal JAK-STAT signaling as one of the signature pathways activated in round spheroids. Accordingly, STAT3 inhibition in spheroids generated from the established cancer cells and primary glioblastoma patient-derived cells altered the rounded morphology and increased drug sensitivity. Furthermore, combined administration of the STAT3 inhibitor and 5-fluorouracil to a mouse xenograft model markedly reduced tumor growth compared with monotherapy. Collectively, our findings demonstrate the ability to integrate 3D culture and genetic profiling to determine the factors underlying the integrity of the permeability barrier in the tumor microenvironment, and may help to identify and exploit novel mechanisms of drug resistance.
Insights
Researchers identified round multicellular tumor spheroids as having a permeability barrier, linked to JAK-STAT signaling. Inhibiting STAT3 in these spheroids and in mouse models improved anticancer drug delivery and sensitivity, offering new strategies for drug resistance.
Area of Science:
- Oncology
- Cancer Biology
- Drug Delivery
Background:
- Tumor permeability significantly impacts drug delivery and treatment effectiveness.
- Lack of systematic methods to identify factors creating tumor microenvironment permeability barriers.
- Multicellular tumor spheroids (MTS) offer a 3D in vitro model to study tumor behavior.
Purpose of the Study:
- To identify cellular processes and pathways associated with spheroid structure and permeability barriers.
- To correlate spheroid morphology with genetic information to understand tumor microenvironment functions.
- To investigate the role of JAK-STAT signaling in tumor spheroid permeability and drug resistance.
Main Methods:
- Generated and classified spheroids from 100 cancer cell lines based on morphology.
- Correlated spheroid morphology with genetic data to identify key cellular processes.
- Utilized STAT3 inhibition in spheroids and a mouse xenograft model to assess drug sensitivity and tumor growth.
Main Results:
- Identified four distinct spheroid morphologies, with round, compact spheroids exhibiting hypoxic cores and drug permeability barriers.
- Revealed JAK-STAT signaling as a key pathway activated in round spheroids.
- STAT3 inhibition altered spheroid morphology, enhanced drug sensitivity, and reduced tumor growth in vivo.
Conclusions:
- Integrates 3D culture and genetic profiling to identify factors governing tumor microenvironment permeability barriers.
- JAK-STAT signaling is a critical factor in spheroid integrity and drug resistance.
- Targeting STAT3 offers a potential strategy to overcome drug resistance and improve cancer therapy.
Related Concept Videos
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

